CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Epalrestat

依帕司他 杂质对照品Epalrestat Impurities

43 个杂质条目43 impurity entries

本页汇总 依帕司他 的 43 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 43 impurity reference standards of Epalrestat. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 依帕司他(Epalrestat)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesStudy on degradation kinetics of epalrestat in aqueous solutions and characterization of its major degradation products under stress degradation conditions by UHPLC-PDA-MS/MS
    Journal of pharmaceutical analysis · 2019 · Sun H et al.  ·  PMID 31890342  ·  DOI
  2. 分析方法Analytical MethodsSimultaneous determination of epalrestat and puerarin in rat plasma by UHPLC-MS/MS: Application to their pharmacokinetic interaction study
    Biomedical chromatography : BMC · 2017 · Sun H et al.  ·  PMID 27650591  ·  DOI
  3. 分析方法Analytical MethodsA rapid and sensitive UHPLC-MS/MS method for epalrestat detection in micro-volumes of human plasma for the first time
    Bioanalysis · 2025 · Chen H et al.  ·  PMID 40420470  ·  DOI
  4. 分析方法Analytical MethodsLC-MS/MS method for the quantification of aldose reductase inhibitor-epalrestat and application to pharmacokinetic study
    Journal of pharmaceutical and biomedical analysis · 2013 · Nirogi R et al.  ·  PMID 23245255  ·  DOI

依帕司他 —— 原料药与杂质对照品Epalrestat — drug substance & impurities

共 44 个条目(含原料药本体)44 items incl. the drug substance
Epalrestat structure
原料药 APIAPI
依帕司他Epalrestat
Epalrestat
CAS No.82159-09-9
Chemical FormulaC15H13NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 2 (Epalrestat (Z, Z)-Isomer) structure
2
依帕司他杂质2 (依帕司他(Z,Z)-异构体)Epalrestat Impurity 2 (Epalrestat (Z, Z)-Isomer)
Epalrestat Impurity 2 (Epalrestat (Z, Z)-Isomer)
CAS No.124782-63-4
Chemical FormulaC15H13NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 3(Epalrestat (E, E)-Isomer) structure
3
依帕司他杂质3(依帕司他EE异构体)Epalrestat Impurity 3(Epalrestat (E, E)-Isomer)
Epalrestat Impurity 3(Epalrestat (E, E)-Isomer)
CAS No.863988-85-6
Chemical FormulaC15H13NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 4(Epalrestat (E, Z)-Isomer) structure
4
依帕司他杂质4(依帕司他EZ异构体)Epalrestat Impurity 4(Epalrestat (E, Z)-Isomer)
Epalrestat Impurity 4(Epalrestat (E, Z)-Isomer)
CAS No.124782-64-5
Chemical FormulaC15H13NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 5 structure
5
依帕司他杂质5Epalrestat Impurity 5
Epalrestat Impurity 5
CAS No.1800597-47-0
Chemical FormulaC14H11NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 6 structure
6
依帕司他杂质6Epalrestat Impurity 6
Epalrestat Impurity 6
CAS No.332406-96-9
Chemical FormulaC16H15NOS2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 7 structure
7
依帕司他杂质7Epalrestat Impurity 7
Epalrestat Impurity 7
CAS No.5718-83-2
Chemical FormulaC5H5NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 8 structure
8
依帕司他杂质8Epalrestat Impurity 8
Epalrestat Impurity 8
CAS No.101-39-3
Chemical FormulaC10H10O
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 9 structure
9
依帕司他杂质9Epalrestat Impurity 9
Epalrestat Impurity 9
CAS No.1151944-57-8
Chemical FormulaC12H9NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 10 structure
10
依帕司他杂质10Epalrestat Impurity 10
Epalrestat Impurity 10
CAS No.66051-14-7
Chemical FormulaC10H10O
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 11 structure
11
依帕司他杂质11Epalrestat Impurity 11
Epalrestat Impurity 11
CAS No.682775-70-8
Chemical FormulaC16H15NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 14 structure
14
依帕司他杂质14Epalrestat Impurity 14
Epalrestat Impurity 14
CAS No.130786-32-2
Chemical FormulaC8H9NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 17 structure
17
依帕司他杂质17Epalrestat Impurity 17
Epalrestat Impurity 17
CAS No.109801-00-5
Chemical FormulaC13H18O
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 18 structure
18
依帕司他杂质18Epalrestat Impurity 18
Epalrestat Impurity 18
CAS No.76969-81-8
Chemical FormulaC5H8ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 20 structure
20
依帕司他杂质20Epalrestat Impurity 20
Epalrestat Impurity 20
CAS No.149789-77-5
Chemical FormulaC6H7NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 21 structure
21
依帕司他杂质21Epalrestat Impurity 21
Epalrestat Impurity 21
CAS No.1431637-29-4
Chemical FormulaC12H9NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 22 structure
22
依帕司他杂质22Epalrestat Impurity 22
Epalrestat Impurity 22
CAS No.23176-01-4
Chemical FormulaC7H9NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 23 structure
23
依帕司他杂质23Epalrestat Impurity 23
Epalrestat Impurity 23
CAS No.794510-29-5
Chemical FormulaC15H13NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 28 structure
28
依帕司他杂质28Epalrestat Impurity 28
Epalrestat Impurity 28
CAS No.31061-24-2
Chemical FormulaC5H5NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 29 structure
29
依帕司他杂质29Epalrestat Impurity 29
Epalrestat Impurity 29
CAS No.2041-59-0
Chemical FormulaC3H5NO2S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 29 Diammonium Salt structure
29
依帕司他杂质29 二铵盐Epalrestat Impurity 29 Diammonium Salt
Epalrestat Impurity 29 Diammonium Salt
CAS No.6861-95-6
Chemical FormulaC3H3NO2S22-·2H4N+
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 29 Dipotassium Salt structure
29
依帕司他杂质29 二钾盐Epalrestat Impurity 29 Dipotassium Salt
Epalrestat Impurity 29 Dipotassium Salt
CAS No.81885-12-3
Chemical FormulaC3H5NO2S2·2K
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 31 structure
31
依帕司他杂质31Epalrestat Impurity 31
Epalrestat Impurity 31
CAS No.307538-70-1
Chemical FormulaC14H13NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 32 structure
32
依帕司他杂质32Epalrestat Impurity 32
Epalrestat Impurity 32
CAS No.82159-06-6
Chemical FormulaC12H9NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 33 structure
33
依帕司他杂质33Epalrestat Impurity 33
Epalrestat Impurity 33
CAS No.15174-47-7
Chemical FormulaC10H10O
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 34 Monomer structure
34
依帕司他杂质34 单体Epalrestat Impurity 34 Monomer
Epalrestat Impurity 34 Monomer
CAS No.76046-54-3
Chemical FormulaC6H8N2O4S4
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 36 structure
36
依帕司他杂质36Epalrestat Impurity 36
Epalrestat Impurity 36
CAS No.1199-77-5
Chemical FormulaC10H10O2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 37 structure
37
依帕司他杂质37Epalrestat Impurity 37
Epalrestat Impurity 37
CAS No.179027-75-9
Chemical FormulaC5H5NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 38 structure
38
依帕司他杂质38Epalrestat Impurity 38
Epalrestat Impurity 38
CAS No.682775-71-9
Chemical FormulaC17H17NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 39 structure
39
依帕司他杂质39Epalrestat Impurity 39
Epalrestat Impurity 39
CAS No.149217-17-4
Chemical FormulaC14H20O2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 40 structure
40
依帕司他杂质40Epalrestat Impurity 40
Epalrestat Impurity 40
CAS No.138459-91-3
Chemical FormulaC8H13NOS2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 41 structure
41
依帕司他杂质41Epalrestat Impurity 41
Epalrestat Impurity 41
CAS No.60218-91-9
Chemical FormulaC10H12O2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 43 Monomer structure
43
依帕司他杂质43 单体Epalrestat Impurity 43 Monomer
Epalrestat Impurity 43 Monomer
CAS No.116636-84-1
Chemical FormulaC3H6N2OS2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 44 structure
44
依帕司他杂质44Epalrestat Impurity 44
Epalrestat Impurity 44
CAS No.29677-65-4
Chemical FormulaC5H7NO4S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 45 structure
45
依帕司他杂质45Epalrestat Impurity 45
Epalrestat Impurity 45
CAS No.39486-57-2
Chemical FormulaC5H6N2O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 50 structure
50
依帕司他杂质50Epalrestat Impurity 50
Epalrestat Impurity 50
CAS No.15289-56-2
Chemical FormulaC13H11NOS2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 51 structure
51
依帕司他杂质51Epalrestat Impurity 51
Epalrestat Impurity 51
CAS No.15250-29-0
Chemical FormulaC10H10O2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 55 structure
55
依帕司他杂质55Epalrestat Impurity 55
Epalrestat Impurity 55
CAS No.44912-47-2
Chemical FormulaC5H9NO2S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 56 structure
56
依帕司他杂质56Epalrestat Impurity 56
Epalrestat Impurity 56
CAS No.141-84-4
Chemical FormulaC3H3NOS2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 57 structure
57
依帕司他杂质57Epalrestat Impurity 57
Epalrestat Impurity 57
CAS No.3035759-38-4
Chemical FormulaC16H15NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 58 structure
58
依帕司他杂质58Epalrestat Impurity 58
Epalrestat Impurity 58
CAS No.138165-82-9
Chemical FormulaC4H7NO2S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 59 structure
59
依帕司他杂质59Epalrestat Impurity 59
Epalrestat Impurity 59
CAS No.138722-76-6
Chemical FormulaC5H8N2O3S2
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 61 structure
61
依帕司他杂质61Epalrestat Impurity 61
Epalrestat Impurity 61
CAS No.1408072-62-7
Chemical FormulaC13H14O
Purity>95%询价On request
10mg25mg50mg100mg
Epalrestat Impurity 65 structure
65
依帕司他杂质65Epalrestat Impurity 65
Epalrestat Impurity 65
CAS No.190773-76-3
Chemical FormulaC7H8N2O4S2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

依帕司他 —— 研究文献与合成路线Epalrestat — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 依帕司他 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Epalrestat. Titles link to the original records; copyright remains with the authors and publishers.

合成与制备工艺专利Synthesis & process patents

  1. Epalrestat dropping pills and preparation thereof
    QUANSHENG LIU, MING MA, BING XIA, CAO JUN · 公开号 CN101239046CN101239046 · 2008
  2. MANUFACTURING METHOD OF EPALRESTAT
    IKEDA SHIN, ONOZAWA TAKASHI, SUZUKI YOSHINOBU · 公开号 JP2006104064JP2006104064 · 2006
  3. PROCESS FOR PREPARING RHODANINE-3-ACETIC ACID: A KEY INTERMEDIATED OF EPALRESTAT
    KHAMAR Bakulesh Mafatlal, MODI Indravadan Ambalal, VENKATRAMAN Jayaraman, RAVI Ponnaiah, et al. · 公开号 WO2007074390WO2007074390 · 2007

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

依帕司他 杂质谱研究要点Epalrestat — impurity profiling notes

下面这些是拿到 依帕司他 的 44 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 44 impurity entries for Epalrestat, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances